{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T00:59:22Z","timestamp":1794013162578,"version":"4.8.0"},"reference-count":124,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82102626"],"award-info":[{"award-number":["82102626"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.isci.2026.114842","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:42:50Z","timestamp":1769733770000},"page":"114842","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["FXR in bone metabolism: An emerging regulator"],"prefix":"10.1016","volume":"29","author":[{"given":"S. M. Mahamudul","family":"Hassan Rizvi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aihemaiti","family":"Shami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Kan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengxiang","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2026.114842_bib1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1146\/annurev-pathol-011110-130203","article-title":"Disorders of bone remodeling","volume":"6","author":"Feng","year":"2011","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.isci.2026.114842_bib2","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.95083","article-title":"Current perspectives on the multiple roles of osteoclasts: Mechanisms of osteoclast-osteoblast communication and potential clinical implications","volume":"13","author":"Daponte","year":"2024","journal-title":"eLife"},{"key":"10.1016\/j.isci.2026.114842_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108168","article-title":"Advances in pathogenesis and therapeutic strategies for osteoporosis","volume":"237","author":"Song","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.isci.2026.114842_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2024.112614","article-title":"The interplay between osteoarthritis and osteoporosis: Mechanisms, implications, and treatment considerations - A narrative review","volume":"197","author":"Huang","year":"2024","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.isci.2026.114842_bib5","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s41232-019-0111-3","article-title":"RANKL biology: bone metabolism, the immune system, and beyond","volume":"40","author":"Ono","year":"2020","journal-title":"Inflamm. Regen."},{"key":"10.1016\/j.isci.2026.114842_bib6","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1002\/jbmr.1961","article-title":"Positive regulation of osteogenesis by bile acid through FXR","volume":"28","author":"Cho","year":"2013","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.isci.2026.114842_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/molecules30010058","article-title":"FXR Activation Accelerates Early Phase of Osteoblast Differentiation Through COX-2-PGE(2)-EP4 Axis in BMP-2-Induced Mouse Mesenchymal Stem Cells","volume":"30","author":"Fujimori","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.isci.2026.114842_bib8","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/cr.2008.289","article-title":"FXR: a metabolic regulator and cell protector","volume":"18","author":"Wang","year":"2008","journal-title":"Cell Res."},{"key":"10.1016\/j.isci.2026.114842_bib9","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1159\/000371670","article-title":"Bile Acids as Hormones: The FXR-FGF15\/19 Pathway","volume":"33","author":"Kliewer","year":"2015","journal-title":"Dig. Dis."},{"key":"10.1016\/j.isci.2026.114842_bib10","first-page":"1508","article-title":"Farnesoid X receptor: From Structure to Function and Its Pharmacology in Liver Fibrosis","volume":"15","author":"Ding","year":"2024","journal-title":"Aging Dis."},{"key":"10.1016\/j.isci.2026.114842_bib11","doi-asserted-by":"crossref","DOI":"10.1126\/science.adt0548","article-title":"Osteoarthritis treatment via the GLP-1-mediated gut-joint axis targets intestinal FXR signaling","volume":"388","author":"Yang","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.isci.2026.114842_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2022.111616","article-title":"Enterohepatic and non-canonical roles of farnesoid X receptor in controlling lipid and glucose metabolism","volume":"549","author":"Zhou","year":"2022","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.isci.2026.114842_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2022.111618","article-title":"Discovery of farnesoid X receptor and its role in bile acid metabolism","volume":"548","author":"Chiang","year":"2022","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.isci.2026.114842_bib14","doi-asserted-by":"crossref","first-page":"76558","DOI":"10.18632\/oncotarget.20576","article-title":"The farnesoid X receptor negatively regulates osteoclastogenesis in bone remodeling and pathological bone loss","volume":"8","author":"Zheng","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.isci.2026.114842_bib15","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1177\/0192623317735316","article-title":"Bone and the Immune System","volume":"45","author":"Weitzmann","year":"2017","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.isci.2026.114842_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/nu17050822","article-title":"Polymethoxyflavones and Bone Metabolism","volume":"17","author":"Hirata","year":"2025","journal-title":"Nutrients"},{"key":"10.1016\/j.isci.2026.114842_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154258","article-title":"Activation of farnesoid X receptor signaling by geniposidic acid promotes osteogenesis","volume":"103","author":"Liu","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.isci.2026.114842_bib18","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1016\/j.csbj.2023.05.026","article-title":"Structural basis of the farnesoid X receptor\/retinoid X receptor heterodimer on inverted repeat DNA","volume":"21","author":"Jiang","year":"2023","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.isci.2026.114842_bib19","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1016\/j.csbj.2021.04.029","article-title":"Farnesoid X receptor (FXR): Structures and ligands","volume":"19","author":"Jiang","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.isci.2026.114842_bib20","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1038\/s41401-021-00849-4","article-title":"FXR: structures, biology, and drug development for NASH and fibrosis diseases","volume":"43","author":"Tian","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.isci.2026.114842_bib21","doi-asserted-by":"crossref","DOI":"10.1621\/nrs.08005","article-title":"Deciphering the nuclear bile acid receptor FXR paradigm","volume":"8","author":"Modica","year":"2010","journal-title":"Nucl. Recept. Signal."},{"key":"10.1016\/j.isci.2026.114842_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14246191","article-title":"Regulation of Chromatin Accessibility by the Farnesoid X Receptor Is Essential for Circadian and Bile Acid Homeostasis In Vivo","volume":"14","author":"Hassan","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.isci.2026.114842_bib23","doi-asserted-by":"crossref","first-page":"18180","DOI":"10.1074\/jbc.RA118.004652","article-title":"Ligand binding and heterodimerization with retinoid X receptor \u03b1 (RXR\u03b1) induce farnesoid X receptor (FXR) conformational changes affecting coactivator binding","volume":"293","author":"Wang","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.isci.2026.114842_bib24","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1074\/jbc.M209505200","article-title":"Natural structural variants of the nuclear receptor farnesoid X receptor affect transcriptional activation","volume":"278","author":"Zhang","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.isci.2026.114842_bib25","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.1007\/s00018-019-03247-6","article-title":"Farnesoid X receptor alpha (FXR\u03b1) is a critical actor of the development and pathologies of the male reproductive system","volume":"76","author":"Garcia","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.isci.2026.114842_bib26","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1128\/MCB.23.3.864-872.2003","article-title":"Identification of farnesoid X receptor beta as a novel mammalian nuclear receptor sensing lanosterol","volume":"23","author":"Otte","year":"2003","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.isci.2026.114842_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.875593","article-title":"Reduced peroxisome proliferator-activated receptor-\u03b1 and bile acid nuclear receptor NR1H4\/FXR may affect the hepatic immune microenvironment of biliary atresia","volume":"13","author":"Ma","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.114842_bib28","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1073\/pnas.0400046101","article-title":"Expression and activation of the farnesoid X receptor in the vasculature","volume":"101","author":"Bishop-Bailey","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2026.114842_bib29","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3389\/fmed.2020.00544","article-title":"Bile Acids and FXR: Novel Targets for Liver Diseases","volume":"7","author":"Stofan","year":"2020","journal-title":"Front. Med."},{"key":"10.1016\/j.isci.2026.114842_bib30","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/164_2019_228","article-title":"Pharmacologic Modulation of Bile Acid-FXR-FGF15\/FGF19 Pathway for the Treatment of Nonalcoholic Steatohepatitis","volume":"256","author":"Schumacher","year":"2019","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.isci.2026.114842_bib31","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.160578","article-title":"Minocycline-induced disruption of the intestinal FXR\/FGF15 axis impairs osteogenesis in mice","volume":"8","author":"Carson","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.isci.2026.114842_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19072069","article-title":"Update on FXR Biology: Promising Therapeutic Target?","volume":"19","author":"Han","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2026.114842_bib33","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1124\/jpet.117.246033","article-title":"Farnesoid X Receptor Agonists Obeticholic Acid and Chenodeoxycholic Acid Increase Bile Acid Efflux in Sandwich-Cultured Human Hepatocytes: Functional Evidence and Mechanisms","volume":"365","author":"Guo","year":"2018","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.isci.2026.114842_bib34","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13578-023-01035-1","article-title":"Bile acid-mediated signaling in cholestatic liver diseases","volume":"13","author":"Zeng","year":"2023","journal-title":"Cell Biosci."},{"key":"10.1016\/j.isci.2026.114842_bib35","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/164_2019_231","article-title":"Targeting FXR in Cholestasis","volume":"256","author":"Keitel","year":"2019","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.isci.2026.114842_bib36","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00518-22","article-title":"FXR Signaling-Mediated Bile Acid Metabolism Is Critical for Alleviation of Cholesterol Gallstones by Lactobacillus Strains","volume":"10","author":"Ye","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.isci.2026.114842_bib37","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1042\/BST20190130","article-title":"ABCG5\/G8: a structural view to pathophysiology of the hepatobiliary cholesterol secretion","volume":"47","author":"Zein","year":"2019","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.isci.2026.114842_bib38","doi-asserted-by":"crossref","first-page":"H272","DOI":"10.1152\/ajpheart.01075.2008","article-title":"Antiatherosclerotic effect of farnesoid X receptor","volume":"296","author":"Mencarelli","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.isci.2026.114842_bib39","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.freeradbiomed.2025.06.039","article-title":"FXR overexpression alleviates cholestasis via NLRC4 inflammasome suppression and bile acid homeostasis regulation","volume":"238","author":"Wang","year":"2025","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.isci.2026.114842_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/nu15234864","article-title":"Probiotic Pediococcus pentosaceus Li05 Improves Cholestasis through the FXR-SHP and FXR-FGF15 Pathways","volume":"15","author":"Han","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.isci.2026.114842_bib41","article-title":"Clostridium Scindens Protects Against Vancomycin-Induced Cholestasis and Liver Fibrosis by Activating Intestinal FXR-FGF15\/19 Signaling","volume":"12","author":"Xiao","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.isci.2026.114842_bib42","doi-asserted-by":"crossref","first-page":"G554","DOI":"10.1152\/ajpgi.00223.2019","article-title":"Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy","volume":"318","author":"Chiang","year":"2020","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.isci.2026.114842_bib43","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/toxsci\/kfae029","article-title":"Characterization of individual bile acids in vivo utilizing a novel low bile acid mouse model","volume":"199","author":"Taylor","year":"2024","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.isci.2026.114842_bib44","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1124\/dmd.124.001675","article-title":"CYP7A1 Gene Induction via SHP-Dependent or Independent Mechanisms can Increase the Risk of Drug-Induced Liver Injury Independently or in Synergy with BSEP Inhibition","volume":"52","author":"Niu","year":"2024","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.isci.2026.114842_bib45","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s40168-021-01101-1","article-title":"Review: microbial transformations of human bile acids","volume":"9","author":"Guzior","year":"2021","journal-title":"Microbiome"},{"key":"10.1016\/j.isci.2026.114842_bib46","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.apsb.2015.01.004","article-title":"Bile acid nuclear receptor FXR and digestive system diseases","volume":"5","author":"Ding","year":"2015","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.isci.2026.114842_bib47","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41392-024-01811-6","article-title":"Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets","volume":"9","author":"Fleishman","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.isci.2026.114842_bib48","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1152\/physiol.00020.2008","article-title":"The role of FXR in disorders of bile acid homeostasis","volume":"23","author":"Eloranta","year":"2008","journal-title":"Physiology"},{"key":"10.1016\/j.isci.2026.114842_bib49","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/hep.25740","article-title":"Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bile-acid synthesis in mice","volume":"56","author":"Kong","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.isci.2026.114842_bib50","doi-asserted-by":"crossref","first-page":"12604","DOI":"10.1074\/jbc.M109.094524","article-title":"A pathway involving farnesoid X receptor and small heterodimer partner positively regulates hepatic sirtuin 1 levels via microRNA-34a inhibition","volume":"285","author":"Lee","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.isci.2026.114842_bib51","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1074\/jbc.M109326200","article-title":"Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor","volume":"277","author":"Kast","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.isci.2026.114842_bib52","doi-asserted-by":"crossref","first-page":"787","DOI":"10.2174\/138920007782798171","article-title":"Multidrug resistance associated proteins as determining factors of pharmacokinetics and pharmacodynamics of drugs","volume":"8","author":"Yu","year":"2007","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.isci.2026.114842_bib53","doi-asserted-by":"crossref","first-page":"G979","DOI":"10.1152\/ajpgi.00370.2011","article-title":"Bile acids via FXR initiate the expression of major transporters involved in the enterohepatic circulation of bile acids in newborn mice","volume":"302","author":"Cui","year":"2012","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.isci.2026.114842_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2022.111617","article-title":"Fibroblast growth factor 15\/19 expression, regulation, and function: An overview","volume":"548","author":"Guthrie","year":"2022","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.isci.2026.114842_bib55","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41413-024-00394-w","article-title":"Nuclear farnesoid X receptor protects against bone loss by driving osteoblast differentiation through stabilizing RUNX2","volume":"13","author":"Dong","year":"2025","journal-title":"Bone Res."},{"key":"10.1016\/j.isci.2026.114842_bib56","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/jbmr.3652","article-title":"Dual Targeting of Bile Acid Receptor-1 (TGR5) and Farnesoid X Receptor (FXR) Prevents Estrogen-Dependent Bone Loss in Mice","volume":"34","author":"Li","year":"2019","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.isci.2026.114842_bib57","article-title":"Liver-bone crosstalk in non-alcoholic fatty liver disease: Clinical implications and underlying pathophysiology","volume":"14","author":"Zhao","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.isci.2026.114842_bib58","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.675385","article-title":"The Role of Osteoclast Energy Metabolism in the Occurrence and Development of Osteoporosis","volume":"12","author":"Da","year":"2021","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.isci.2026.114842_bib60","doi-asserted-by":"crossref","first-page":"207","DOI":"10.11005\/jbm.2017.24.4.207","article-title":"Fexaramine Inhibits Receptor Activator of Nuclear Factor-\u03baB Ligand-induced Osteoclast Formation via Nuclear Factor of Activated T Cells Signaling Pathways","volume":"24","author":"Zheng","year":"2017","journal-title":"J. Bone Metab."},{"key":"10.1016\/j.isci.2026.114842_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155124","article-title":"Wedelolactone alleviates cholestatic liver injury by regulating FXR-bile acid-NF-\u03baB\/NRF2 axis to reduce bile acid accumulation and its subsequent inflammation and oxidative stress","volume":"122","author":"Wang","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.isci.2026.114842_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2020.109235","article-title":"Ellagic acid blocks RANKL-RANK interaction and suppresses RANKL-induced osteoclastogenesis by inhibiting RANK signaling pathways","volume":"331","author":"Xu","year":"2020","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.isci.2026.114842_bib63","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12102292","article-title":"The Pathogenetic Role of RANK\/RANKL\/OPG Signaling in Osteoarthritis and Related Targeted Therapies","volume":"12","author":"Di Cicco","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.isci.2026.114842_bib64","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.coph.2005.06.005","article-title":"Osteoprotegerin and RANKL regulate bone resorption, density, geometry and strength","volume":"5","author":"Kostenuik","year":"2005","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.isci.2026.114842_bib65","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.21037\/tcr-2025-522","article-title":"FXR activation suppresses NF-\u03baB signaling, proliferation and migration in cervical cancer cells","volume":"14","author":"Li","year":"2025","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.isci.2026.114842_bib66","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1111\/j.1365-2362.2011.02545.x","article-title":"Effects of inflammatory and anti-inflammatory cytokines on the bone","volume":"41","author":"Schett","year":"2011","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.isci.2026.114842_bib67","doi-asserted-by":"crossref","first-page":"504","DOI":"10.3803\/EnM.2023.501","article-title":"Nuclear Factor-Kappa B Regulation of Osteoclastogenesis and Osteoblastogenesis","volume":"38","author":"Boyce","year":"2023","journal-title":"Endocrinol. Metab."},{"key":"10.1016\/j.isci.2026.114842_bib68","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1210\/endo.142.3.8031","article-title":"Receptor activator of nuclear factor-kappa b ligand activates nuclear factor-kappa b in osteoclast precursors","volume":"142","author":"Wei","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.isci.2026.114842_bib69","doi-asserted-by":"crossref","first-page":"6251","DOI":"10.4049\/jimmunol.0803978","article-title":"The bile acid receptor FXR is a modulator of intestinal innate immunity","volume":"183","author":"Vavassori","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.isci.2026.114842_bib70","article-title":"Farnesoid X receptor agonist attenuates subchondral bone osteoclast fusion and osteochondral pathologies of osteoarthritis via suppressing JNK1\/2\/NFATc1 pathway","volume":"36","author":"Hu","year":"2022","journal-title":"FASEB J."},{"key":"10.1016\/j.isci.2026.114842_bib71","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1002\/hep.22519","article-title":"Farnesoid X receptor antagonizes nuclear factor kappaB in hepatic inflammatory response","volume":"48","author":"Wang","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.isci.2026.114842_bib72","doi-asserted-by":"crossref","first-page":"8309","DOI":"10.2147\/DDDT.S541290","article-title":"Ginkgolide B Alleviates LPS-Induced Inhibition of Osteogenic Differentiation in Human Periodontal Ligament Stem Cells by Suppressing the p-I\u03baB\u03b1\/NF-\u03baB Pathway","volume":"19","author":"Du","year":"2025","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.isci.2026.114842_bib73","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00774-020-01162-6","article-title":"Osteoclast differentiation by RANKL and OPG signaling pathways","volume":"39","author":"Udagawa","year":"2021","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.isci.2026.114842_bib74","article-title":"The RANK-RANKL-OPG System: A Multifaceted Regulator of Homeostasis, Immunity, and Cancer","volume":"59","author":"De Leon-Oliva","year":"2023","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.isci.2026.114842_bib75","doi-asserted-by":"crossref","first-page":"706","DOI":"10.14348\/molcells.2017.0225","article-title":"Current Understanding of RANK Signaling in Osteoclast Differentiation and Maturation","volume":"40","author":"Park","year":"2017","journal-title":"Mol. Cells"},{"key":"10.1016\/j.isci.2026.114842_bib76","first-page":"209","article-title":"Rank\/Rankl\/opg: literature review","volume":"36","author":"Silva","year":"2011","journal-title":"Acta Reumatol. Port."},{"key":"10.1016\/j.isci.2026.114842_bib77","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2147\/DDDT.S493711","article-title":"Specnuezhenide Alleviates Senile Osteoporosis by Activating TGR5\/FXR Signaling in Bone Marrow Mesenchymal Stem Cells and RANKL-Induced Osteoclasts","volume":"19","author":"Deng","year":"2025","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.isci.2026.114842_bib78","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0088011","article-title":"Human FXR regulates SHP expression through direct binding to an LRH-1 binding site, independent of an IR-1 and LRH-1","volume":"9","author":"Hoeke","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2026.114842_bib79","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1063815","article-title":"The RANK\/RANKL\/OPG system and tumor bone metastasis: Potential mechanisms and therapeutic strategies","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.isci.2026.114842_bib80","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1007\/s11914-023-00824-4","article-title":"Inflammatory Processes Affecting Bone Health and Repair","volume":"21","author":"Torres","year":"2023","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.isci.2026.114842_bib81","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23031786","article-title":"Interplay between Inflammation and Pathological Bone Resorption: Insights into Recent Mechanisms and Pathways in Related Diseases for Future Perspectives","volume":"23","author":"Terkawi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2026.114842_bib82","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/s41423-025-01289-4","article-title":"FXR protects against neonatal sepsis by enhancing the immunosuppressive function of MDSCs","volume":"22","author":"He","year":"2025","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.isci.2026.114842_bib83","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/hep4.1478","article-title":"Farnesoid X Receptor Activation Protects Liver From Ischemia\/Reperfusion Injury by Up-Regulating Small Heterodimer Partner in Kupffer Cells","volume":"4","author":"Jin","year":"2020","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.isci.2026.114842_bib84","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00011-014-0780-y","article-title":"Role of farnesoid X receptor in inflammation and resolution","volume":"64","author":"Shaik","year":"2015","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.isci.2026.114842_bib85","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.bone.2011.08.013","article-title":"Role of farnesoid X receptor (FXR) in the process of differentiation of bone marrow stromal cells into osteoblasts","volume":"49","author":"Id Boufker","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.isci.2026.114842_bib86","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.biocel.2016.05.015","article-title":"The role of the wnt\/\u03b2-catenin signaling pathway in formation and maintenance of bone and teeth","volume":"77","author":"Duan","year":"2016","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.isci.2026.114842_bib87","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1029130","article-title":"Wnt signaling pathway inhibitors, sclerostin and DKK-1, correlate with pain and bone pathology in patients with Gaucher disease","volume":"13","author":"Ivanova","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.isci.2026.114842_bib88","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24224155","article-title":"Synthesis of Novel Farnesoid X Receptor Agonists and Validation of Their Efficacy in Activating Differentiation of Mouse Bone Marrow-Derived Mesenchymal Stem Cells into Osteoblasts","volume":"24","author":"Fujimori","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.isci.2026.114842_bib89","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41574-019-0246-y","article-title":"The role of osteoblasts in energy homeostasis","volume":"15","author":"Dirckx","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.isci.2026.114842_bib90","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/joim.12348","article-title":"Bone and the regulation of global energy balance","volume":"277","author":"Zhang","year":"2015","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.isci.2026.114842_bib91","doi-asserted-by":"crossref","DOI":"10.3390\/biom14080970","article-title":"Sirt1: An Increasingly Interesting Molecule with a Potential Role in Bone Metabolism and Osteoporosis","volume":"14","author":"Chen","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.isci.2026.114842_bib92","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature03354","article-title":"Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1","volume":"434","author":"Rodgers","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.114842_bib93","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.tem.2010.08.006","article-title":"PPAR\u03b3 in bone homeostasis","volume":"21","author":"Wan","year":"2010","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.isci.2026.114842_bib94","doi-asserted-by":"crossref","DOI":"10.1155\/PPAR\/2006\/52950","article-title":"Fine-Tuning Reception in the Bone: PPARgamma and Company","volume":"2006","author":"Floyd","year":"2006","journal-title":"PPAR Res."},{"key":"10.1016\/j.isci.2026.114842_bib95","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1172\/JCI200419900","article-title":"PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors","volume":"113","author":"Akune","year":"2004","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.isci.2026.114842_bib96","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.gde.2008.07.016","article-title":"Coordination of inflammation and metabolism by PPAR and LXR nuclear receptors","volume":"18","author":"Hong","year":"2008","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.isci.2026.114842_bib97","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrm3312","article-title":"Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR","volume":"13","author":"Calkin","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.isci.2026.114842_bib98","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqaa178","article-title":"The Vitamin D Receptor in Osteoblast-Lineage Cells Is Essential for the Proresorptive Activity of 1\u03b1,25(OH)2D3 In Vivo","volume":"161","author":"Mori","year":"2020","journal-title":"Endocrinology"},{"key":"10.1016\/j.isci.2026.114842_bib99","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1186\/s13018-023-04320-4","article-title":"Modulation of the vitamin D\/vitamin D receptor system in osteoporosis pathogenesis: insights and therapeutic approaches","volume":"18","author":"Li","year":"2023","journal-title":"J. Orthop. Surg. Res."},{"key":"10.1016\/j.isci.2026.114842_bib100","doi-asserted-by":"crossref","DOI":"10.3390\/nu13124499","article-title":"Exercise and Nutrition Impact on Osteoporosis and Sarcopenia-The Incidence of Osteosarcopenia: A Narrative Review","volume":"13","author":"Papadopoulou","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.isci.2026.114842_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2025.112245","article-title":"The gut microbiota-derived metabolites regulate bone extracellular matrix homeostasis: Mechanisms and therapeutic implications","volume":"138","author":"Li","year":"2026","journal-title":"Cell. Signal."},{"key":"10.1016\/j.isci.2026.114842_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106943","article-title":"Bile acid metabolism regulatory network orchestrates bone homeostasis","volume":"196","author":"Xiang","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.isci.2026.114842_bib103","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1111\/liv.14630","article-title":"Bilirubin and bile acids in osteocytes and bone tissue. Potential role in the cholestatic-induced osteoporosis","volume":"40","author":"Ruiz-Gasp\u00e0","year":"2020","journal-title":"Liver Int."},{"key":"10.1016\/j.isci.2026.114842_bib104","doi-asserted-by":"crossref","first-page":"313","DOI":"10.37349\/etat.2020.00019","article-title":"Potential of guggulsterone, a farnesoid X receptor antagonist, in the prevention and treatment of cancer","volume":"1","author":"Girisa","year":"2020","journal-title":"Explor Target Antitumor Ther."},{"key":"10.1016\/j.isci.2026.114842_bib105","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.1242\/jcs.00082","article-title":"JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation-dependent and -independent mechanisms","volume":"115","author":"David","year":"2002","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.isci.2026.114842_bib106","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jot.2022.07.007","article-title":"Peptide modified geniposidic acid targets bone and effectively promotes osteogenesis","volume":"38","author":"Liu","year":"2023","journal-title":"J. Orthop. Translat."},{"key":"10.1016\/j.isci.2026.114842_bib107","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.apsb.2022.08.019","article-title":"SIRT1 activation synergizes with FXR agonism in hepatoprotection via governing nucleocytoplasmic shuttling and degradation of FXR","volume":"13","author":"Cui","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.isci.2026.114842_bib124","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202100451R","article-title":"Gut microbiota and bone metabolism","volume":"35","author":"Lu","year":"2021","journal-title":"Faseb j"},{"key":"10.1016\/j.isci.2026.114842_bib125","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106930","article-title":"Estrogen deficiency induces bone loss through the gut microbiota","volume":"196","author":"Guan","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.isci.2026.114842_bib108","doi-asserted-by":"crossref","first-page":"9960","DOI":"10.1021\/acs.jmedchem.7b00907","article-title":"Discovery of Tropifexor (LJN452), a Highly Potent Non-bile Acid FXR Agonist for the Treatment of Cholestatic Liver Diseases and Nonalcoholic Steatohepatitis (NASH)","volume":"60","author":"Tully","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.isci.2026.114842_bib109","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1007\/s40265-016-0616-x","article-title":"Obeticholic Acid: First Global Approval","volume":"76","author":"Markham","year":"2016","journal-title":"Drugs"},{"key":"10.1016\/j.isci.2026.114842_bib110","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1186\/s12891-015-0807-8","article-title":"Osteoarthritis and frailty in elderly individuals across six European countries: results from the European Project on OSteoArthritis (EPOSA)","volume":"16","author":"Castell","year":"2015","journal-title":"BMC Musculoskelet. Disord."},{"key":"10.1016\/j.isci.2026.114842_bib111","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.joca.2021.05.007","article-title":"The burden of OA-health services and economics","volume":"30","author":"Leifer","year":"2022","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.isci.2026.114842_bib112","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.joca.2009.03.002","article-title":"Aging and osteoarthritis: the role of chondrocyte senescence and aging changes in the cartilage matrix","volume":"17","author":"Loeser","year":"2009","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.isci.2026.114842_bib113","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23116316","article-title":"Cartilage Homeostasis and Osteoarthritis","volume":"23","author":"Fujii","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2026.114842_bib114","doi-asserted-by":"crossref","DOI":"10.1186\/ar4133","article-title":"MMP13 is a critical target gene during the progression of osteoarthritis","volume":"15","author":"Wang","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.isci.2026.114842_bib115","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/joim.12594","article-title":"Treatment with the natural FXR agonist chenodeoxycholic acid reduces clearance of plasma LDL whilst decreasing circulating PCSK9, lipoprotein(a) and apolipoprotein C-III","volume":"281","author":"Ghosh Laskar","year":"2017","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.isci.2026.114842_bib116","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1053\/j.gastro.2014.08.042","article-title":"The bile acid receptor TGR5 activates the TRPA1 channel to induce itch in mice","volume":"147","author":"Lieu","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.isci.2026.114842_bib117","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.pharmthera.2018.06.009","article-title":"Progress and challenges of selective Farnesoid X Receptor modulation","volume":"191","author":"Massafra","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.isci.2026.114842_bib118","doi-asserted-by":"crossref","first-page":"6082","DOI":"10.1021\/acs.jmedchem.2c01918","article-title":"Discovery of the First-in-Class Intestinal Restricted FXR and FABP1 Dual Modulator ZLY28 for the Treatment of Nonalcoholic Fatty Liver Disease","volume":"66","author":"Ren","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.isci.2026.114842_bib119","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/ijcp.12022","article-title":"Denosumab: mechanism of action and clinical outcomes","volume":"66","author":"Hanley","year":"2012","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.isci.2026.114842_bib120","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23116046","article-title":"Molecular Basis of Bile Acid-FXR-FGF15\/19 Signaling Axis","volume":"23","author":"Katafuchi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2026.114842_bib121","article-title":"FXR\/TGR5 mediates inflammasome activation and host resistance to bacterial infection","volume":"27","author":"Kang","year":"2021","journal-title":"Biochem. Biophys. Rep."},{"key":"10.1016\/j.isci.2026.114842_bib122","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2024.1447878","article-title":"Regulation of bile acids and their receptor FXR in metabolic diseases","volume":"11","author":"Li","year":"2024","journal-title":"Front. Nutr."},{"key":"10.1016\/j.isci.2026.114842_bib123","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24098445","article-title":"Non-Alcoholic Fatty Liver Disease and Bone Tissue Metabolism: Current Findings and Future Perspectives","volume":"24","author":"Drapkina","year":"2023","journal-title":"Int. J. Mol. Sci."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226002178?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226002178?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T10:47:57Z","timestamp":1788950877000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004226002178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":124,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2589004226002178"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2026.114842","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FXR in bone metabolism: An emerging regulator","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2026.114842","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"114842"}}